Company
Neuralymed
We discover and develop revolutionary treatments for neurodegenerative diseases
Also known as Neuraly, Neuraly Inc
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Gaithersburg, MD, United States
- Legal name
- Neuraly Inc
Claim, correct or request removal
Record updated 28 September 2026
About
Neuraly is a clinical-stage biotechnology company whose mission is to translate scientific discoveries in neurology into new drugs that can radically improve and prolong the lives of people suffering from the devastating consequences of diseases such as Parkinson’s disease (PD), Alzheimer’s disease (AD) and other neurodegenerative disorders.
Funding snapshot
- Total raised
- $10.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $10.4M2018-04-10
Funding rounds
- Round, 2018
- $10.4M2018-04-10, SEC form D sold, 25 investors
- Round, 2016
- $100K2016-09-16, SEC form D sold, 2 investors
Products
- Other
- NLY01
Loading relationship preview